HSIC|Analyst Targets
HSIC|Company Info
HSIC|Insider Trading
HSIC|Fundamentals
HSIC|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.36 | - | - |
| Q2'26 | $1.26 | $1.27 | +0.7% |
| Q1'26 | $1.22 | $1.32 | +8.4% |
| Q4'25 | $1.26 | $1.34 | +6.3% |
| Q3'25 | $1.28 | $1.38 | +7.9% |
| Q2'25 | $1.19 | $1.10 | -7.6% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $3.5B | - | - |
| Q2'26 | $3.4B | $3.5B | +0.5% |
| Q1'26 | $3.4B | $3.4B | -0.2% |
| Q4'25 | $3.3B | $3.4B | +3.1% |
| Q3'25 | - | $3.3B | - |
| Q2'25 | - | $3.2B | - |
HSIC|Monthly Returns
Market Data
HSIC Stock Snapshot
- Market cap
- 9.40B
- P/E ratio
- 23.3
- Day range
- $84.56 – $86.25
- News sentiment
- 56/100 · Neutral
- Analyst target
- $97.27 (+13.7%)
- Consensus
- Hold · 26 analysts
HSIC's technical picture is constructive, with trend and momentum pointing the same direction. Company-specific news dominates here; sector-level flows matter less than for larger names.
Reverse DCF
What growth is priced into HSIC?
At today's price, Henry Schein, Inc. needs to grow free cash flow about 4.2% a year for the next 10 years to justify its valuation at a 7.45% cost of capital. Over its actual history it has compounded free cash flow at 2.6% a year, so the market is asking for 1.6 percentage points above its own delivered rate. On that basis HSIC looks priced roughly in line with its own growth record.
- Implied FCF growth
- 4.2%
- Historical FCF CAGR
- 2.6%
- Growth gap
- +1.6 pts
- Verdict
- FAIR
- Discount rate (WACC)
- 7.45%
- Beta
- 0.69
Behaviour On Record
What HSIC's own history says about today's numbers
- Realized volatility (21d)
- 24.9% 63rd pct
- Below its peak
- -5.3%
- vs 200-day average
- +8.2%
- Up days (1y)
- 52%
Henry Schein, Inc. is currently running 24.9% annualised volatility over the last 21 sessions. Measured against HSIC's own 13 years of daily returns rather than a market-wide average, that is the 63rd percentile — a little above its own norm, against a typical reading of 22.3%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
HSIC is trading -5.3% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -20.3%, and the deepest was -40.9% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +8.2% from its 200-day moving average. Against every other day in its history, that gap ranks at the 74th percentile — a somewhat wider gap than its own norm. Over the past year HSIC closed higher on 52% of sessions, and it is currently 4 sessions into a rising streak.
On October specifically: over 14 years of records, HSIC finished the month higher 6 of 14 times, with a median return of -1.6% and an average of -0.2%. Its strongest month historically has been November at +4.7% on average, its weakest August at -3.5%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: HSIC has opened more than 2% away from the prior close in 113 of 3,267 sessions (3.5% of the time), with the largest gaps running +5.2% and -10.6%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, HSIC moved an average of 1.6% in the session after earnings, closing higher 1 of those 3 times, with a median move of -1.7% and a largest of -2.6%.
All figures computed from 3,269 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against HSIC's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of HSIC's sector?
Henry Schein, Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
Analyst Rating Changes
Are analysts turning bullish or bearish on HSIC?
BTIG most recently reiterated its rating on Henry Schein, Inc. to Buy on Aug 19, 2026 with a price target of $110 (from $100). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- BTIG — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Peers & ETF holders
HSIC peers & ETF holders
Medical DistributionMarket cap · today
- HSICYou're here$9.4B-0.01%
- MCKMcKesson Corporation$112.3B-0.19%
- CORCencora, Inc.$63.0B-0.01%
- CAHCardinal Health, Inc.$55.1B-1.13%
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▼ Sell | 11,588,199 | 10.48% | $875.84M | 2026-01-29 |
| FMR LLC (Fidelity) | ▲ Buy | 7,553,901 | 6.83% | $630.90M | 2026-08-13 |
| BlackRock, Inc. | ▲ Buy | 7,024,663 | 6.35% | $586.70M | 2026-08-07 |
| Artisan Partners Limited Partnership | ▼ Sell | 6,467,467 | 5.85% | $540.16M | 2026-08-13 |
| JPMorgan Chase & Co | ▼ Sell | 4,342,929 | 3.93% | $366.43M | 2026-08-12 |
| Invesco Ltd. | ▼ Sell | 3,150,237 | 2.85% | $263.11M | 2026-08-14 |
| Citadel Advisors LLC | ▲ Buy | 2,921,103 | 2.64% | $243.97M | 2026-09-02 |
| Geode Capital Management, LLC | ▼ Sell | 2,729,030 | 2.47% | $227.54M | 2026-08-12 |
| Morgan Stanley | ▲ Buy | 2,100,819 | 1.90% | $175.46M | 2026-08-13 |
| Norges Bank | ▲ Buy | 1,237,832 | 1.12% | $103.38M | 2026-08-12 |
| Bank of America Corp | ▼ Sell | 1,212,477 | 1.10% | $101.27M | 2026-08-14 |
| Goldman Sachs Group Inc | ▲ Buy | 1,174,216 | 1.06% | $98.07M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 964,424 | 0.87% | $80.55M | 2026-08-13 |
| Balyasny Asset Management L.P. | ▲ Buy | 232,302 | 0.21% | $19.40M | 2026-08-14 |
| Man Group plc | ▼ Sell | 95,490 | 0.09% | $7.98M | 2026-08-14 |
| Neuberger Berman Group LLC | ▼ Sell | 81,501 | 0.07% | $6.81M | 2026-08-13 |
| AllianceBernstein L.P. | ▼ Sell | 91,173 | 0.08% | $6.72M | 2026-08-14 |
| Wells Fargo & Company | ▲ Buy | 76,085 | 0.07% | $6.35M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 75,667 | 0.07% | $6.32M | 2026-08-03 |
| Squarepoint Ops LLC | ▲ Buy | 64,285 | 0.06% | $5.37M | 2026-08-14 |
| Bridgewater Associates, LP | ▲ Buy | 58,993 | 0.05% | $4.93M | 2026-08-14 |
| Prudential Financial Inc | ▲ Buy | 50,357 | 0.05% | $4.21M | 2026-08-12 |
| Janus Henderson Group plc | ▼ Sell | 49,166 | 0.04% | $3.62M | 2026-05-18 |
| Marshall Wace, LLP | ▼ Sell | 37,550 | 0.03% | $3.14M | 2026-08-13 |
| Point72 Asset Management, L.P. | ▼ Sell | 37,402 | 0.03% | $3.12M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-04-08 | 2025-05-08 |
| Julie Johnson | House | TX32 | ▼ Sell | $1K - $15K | 2025-04-01 | 2025-05-14 |
| Gilbert Cisneros | House | CA31 | ▼ Sell | $1K - $15K | 2025-03-31 | 2025-04-07 |
| Susan M. Collins | Senate | ME | ▼ Sell | $15K - $50K | 2022-01-06 | 2022-02-17 |
| Susan M. Collins | Senate | ME | ▲ Buy | $1K - $15K | 2014-11-10 | 2014-12-01 |
| Susan M. Collins | Senate | ME | ▲ Buy | $1K - $15K | 2014-07-23 | 2015-07-20 |